Alkem Laboratories Ltd.NSE: ALKEM

Press Release (Revised) Jun 10 2021

· Issued by Alkem Laboratories Ltd.

Filed with NSE ·

Alkem Laboratories Limited has informed the Exchange regarding a revised press release dated Jun 10, 2021, titled "ALKEM launches Perampanel Tablets in India under the brand name Perampil for treatment of Epilepsy.".

View Attachment

6ix hasn’t read this filing yet.

Alkem Laboratories Ltd. on 6ix

Earlier from Alkem Laboratories

Later from Alkem Laboratories

All Alkem Laboratories news releases